Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microwave dielectric tissue property imaging is a biomedical imaging modality that reconstructs images based on tissue-dependent dielectric contrasts—differences in electrical properties such as relative permittivity and conductivity—which vary among different tissue types and states of disease (e.g., malignant versus healthy tissue)[1][2][3]. These differences enable the detection and characterization of pathological structures using radar-based or tomographic algorithms, with particular application in breast cancer detection, cardiac imaging, brain imaging, and lung imaging[2][3]. The dielectric properties are chiefly determined by tissue water content, metabolic activity, necrosis, and inflammation, which alter the electrical characteristics and thus the interaction with microwave signals[1][3]. The technique is non-ionizing and may be cost-effective and safe compared to conventional imaging modalities such as CT, PET, or MRI, but is not itself a molecular or pharmacological target[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microwave dielectric tissue property imaging.